Jpmorgan Chase & CO Medi Wound Ltd. Transaction History

Jpmorgan Chase & CO

  • $1.1 Trillion
  • Q1 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 11, 2022
SELL
$1.33 - $2.35 $3,948 - $6,977
-2,969 Closed
0 $0
Q1 2022

May 11, 2022
SELL
$1.86 - $3.24 $47,374 - $82,522
-25,470 Reduced 89.56%
2,969 $6,000
Q4 2021

Feb 10, 2022
SELL
$2.2 - $4.01 $136,633 - $249,045
-62,106 Reduced 68.59%
28,439 $67,000
Q3 2021

Nov 12, 2021
BUY
$3.34 - $4.63 $302,420 - $419,223
90,545 New
90,545 $301,000

About MediWound Ltd.

MDWD Quotes by TradingView
  • Ticker MDWD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,735,200
  • Market Cap $789M
  • Description
  • MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel and bio-therapeutic solutions for tissue repair and regeneration. It markets NexoBrid, a biopharmaceutical product for the removal of eschar, a dead or damaged tissue in adults with deep partial- and full-thickness thermal burns to burn centers and hosp...
More about MDWD
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email